EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 TrialL. Perrier,K. Zarca, T. Cadet,M. Morelle,C. Cropet,A. Burges,S.C. Cecere,I. Palacio, S. Polterauer, H. Yoshida,P. Vuylsteke,N. Colombo,T.J. Nøttrup,C. Abdeddaim,A. El-Balat,S. Cinieri,A. Herrero, M.C. Kaminski,E. Pujade-Lauraine,I. Durand-Zaleski,I. Ray-CoquardValue in Health（2023）引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
